MAIA Biotechnology Director Ramiro Guerrero Buys 133,790 Shares

What Happened
Ramiro Guerrero, a director of MAIA Biotechnology, reported three acquisitions (code P) of company stock via open-market or private purchases: 8,931 shares at $1.39 on Aug 26, 2026 ($12,414); 78,239 shares at $1.39 on Aug 27, 2026 ($108,752); and 46,620 shares at $1.35 on Aug 28, 2026 ($62,937). Total purchased = 133,790 shares for $184,103. These were outright purchases (acquisitions), which many investors view as a more informative signal than routine sales.

Key Details

• Transaction dates & prices:
  • 2026-08-26: 8,931 shares @ $1.39 = $12,414 (P)
  • 2026-08-27: 78,239 shares @ $1.39 = $108,752 (P)
  • 2026-08-28: 46,620 shares @ $1.35 = $62,937 (P)
• Total: 133,790 shares purchased for $184,103.
• Filing: Form 4 filed Sept 1, 2026 (accession 0001878313-26-000082).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnotes/plans: no 10b5-1 plan, tax withholding, or other special footnotes indicated in the supplied details.
• Timeliness: filing date is Sept 1, 2026; no late-filing flag was identified in the provided information.

Context
Code P denotes a purchase (acquisition) of shares. Purchases by company insiders (especially officers/directors) can be interpreted by some investors as a sign of confidence, but they are not proof of future performance. This summary is factual only—motivations for the purchases are not stated in the filing.